Impact of vascular calcification on corrected QT interval at the time of renal transplantation

American Journal of Nephrology

Volumn 35, Issue 1, 2012, Pages 24-30

  Claes, Kathleen J ^a   Heye, Sam ^a   Nuyens, Dieter ^a   Bammens, Bert ^a   Kuypers, Dirk R ^a   Vanrenterghem, Yves ^a   Evenepoel, Pieter ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Chronic kidney disease stage V; Dialysis; QT interval; Vascular calcification

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD VESSEL CALCIFICATION; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ELECTROLYTE DISTURBANCE; FEMALE; HEART CONDUCTION; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MINERAL METABOLISM; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; SEX DIFFERENCE; SPINE RADIOGRAPHY;

AGED; AORTA; CROSS-SECTIONAL STUDIES; ELECTROCARDIOGRAPHY; ELECTROLYTES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RADIOIMMUNOASSAY; SEX FACTORS; TREATMENT OUTCOME; VASCULAR CALCIFICATION;

EID: 82655172741     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000334597     Document Type: Article

References (27)

1. Wang AY, Lam CW, Chan IH, Wang M, Lui SF, Sanderson JE: Sudden cardiac death in end-stage renal disease patients: a 5-year prospective analysis. Hypertension 2010; 56: 210-216.
2. Longenecker JC, Coresh J, Powe NR, Levey AS, Fink NE, Martin A, Klag MJ: Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study. J Am Soc Nephrol 2002; 13: 1918-1927. (Pubitemid 34700618)
3. Silberberg JS, Barre PE, Prichard SS, Sniderman AD: Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 1989; 36: 286-290. (Pubitemid 19202488)
4. Schouten EG, Dekker JM, Meppelink P, Kok FJ, Vandenbroucke JP, Pool J: QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation 1991; 84: 1516-1523.
5. Hage FG, de Mattos AM, Khamash H, Mehta S, Warnock D, Iskandrian AE: QT prolongation is an independent predictor of mortality in end-stage renal disease. Clin Cardiol 2010; 33: 361-366.
6. Krane V, Heinrich F, Meesmann M, Olschewski M, Lilienthal J, Angermann C, Stärk S, Bauersachs J, Wanner C, Frantz S, German Diabetes and Dialysis Study Investigators: Electrocardiography and outcome in patients with diabetes mellitus on maintenance hemodialysis. Clin J Am Soc Nephrol 2009; 4: 394-400.
7. Festa A, D'Agostino R Jr, Rautaharju P, O'Leary DH, Rewers M, Mykkanen L, Haffner SM: Is QT interval a marker of subclinical atherosclerosis in nondiabetic subjects? The Insulin Resistance Atherosclerosis Study (IRAS). Stroke 1999; 30: 1566-1571. (Pubitemid 29379604)
8. Okuno S, Ishimura E, Kitatani K, Fujino Y, Kohno K, Maeno Y, Maekawa K, Yamakawa T, Imanishi Y, Inaba M, Nishizawa Y: Presence of abdominal aortic calcification is significantly associated with all-cause and cardiovascular mortality in maintenance hemodialysis patients. Am J Kidney Dis 2007; 49: 417-425.
9. Nelson MR, Daniel KR, Carr JJ, Freedman BI, Prineas RJ, Bowden DW, Herrington DM: Associations between electrocardiographic interval durations and coronary artery calcium scores: the Diabetes Heart Study. Pacing Clin Electrophysiol 2008; 31: 314-321. (Pubitemid 351328749)
10. Pan NH, Yang HY, Hsieh MH, Chen YJ: Coronary calcium score from multislice computed tomography correlates with QT dispersion and left ventricular wall thickness. Heart Vessels 2008; 23: 155-160.
11. Kauppila LI, Polak JF, Cupples LA, Hannan MT, Kiel DP, Wilson PW: New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25- year follow-up study. Atherosclerosis 1997; 132: 245-250. (Pubitemid 27311017)
12. Honkanen E, Kauppila L, Wikstrom B, Rensma PL, Krzesinski JM, Aasarod K, Verbeke F, Jensen PB, Mattelaer P, Volck B, CORD Study Group: Abdominal aortic calcification in dialysis patients: results of the CORD study. Nephrol Dial Transplant 2008; 23: 4009-4015.
13. Covic A, Diaconita M, Gusbeth-Tatomir P, Covic M, Botezan A, Ungureanu G, Goldsmith DJ: Haemodialysis increases QTc interval but not QTc dispersion in ESRD patients without manifest cardiac disease. Nephrol Dial Transplant 2002; 17: 2170-2177. (Pubitemid 35446674)
14. Di Iorio BR, Bortone S, Piscopo C, Grimaldi P, Cucciniello E, D'Avanzo E, Mondillo F, Cillo N, Bellizzi V: Cardiac vascular calcification and QT interval in ESRD patients: is there a link? Blood Purif 2006; 24: 451-459. (Pubitemid 46030087)
15. Stewart GA, Gansevoort RT, Mark PB, Rooney E, McDonagh TA, Dargie HJ, Stuart R, Rodger C, Jardine AG: Electrocardiographic abnormalities and uremic cardiomyopathy. Kidney Int 2005; 67: 217-226. (Pubitemid 40019243)
16. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, Barre P: Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995; 47: 186-192.
17. Guerin AP, London GM, Marchais SJ, Metivier F: Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 2000; 15: 1014-1021. (Pubitemid 30410374)
18. Haydar AA, Covic A, Colhoun H, Rubens M, Goldsmith DJ: Coronary artery calcification and aortic pulse wave velocity in chronic kidney disease patients. Kidney Int 2004; 65: 1790-1794. (Pubitemid 38591027)
19. Amann K, Kronenberg G, Gehlen F, Wessels S, Orth S, Munter K, Ehmke H, Mall G, Ritz E: Cardiac remodelling in experimental renal failure - an immunohistochemical study. Nephrol Dial Transplant 1998; 13: 1958-1966. (Pubitemid 28356759)
20. Maebuchi D, Arima H, Ninomiya T, Yonemoto K, Kubo M, Doi Y, Tanizaki Y, Matsumura K, Iida M, Kiyohara Y: Arterial stiffness and QT interval prolongation in a general population: the Hisayama Study. Hypertens Res 2008; 31: 1339-1345.
21. Amann K, Ritz E, Wiest G, Klaus G, Mall G: A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia. J Am Soc Nephrol 1994; 4: 1814-1819.
22. Hara M, Liu YM, Zhen L, Cohen IS, Yu H, Danilo P Jr, Ogino K, Bilezikian JP, Rosen MR: Positive chronotropic actions of parathyroid hormone and parathyroid hormonerelated peptide are associated with increases in the current, I(f), and the slope of the pacemaker potential. Circulation 1997; 96: 3704-3709. (Pubitemid 27513452)
23. Gerdts E, Zabalgoitia M, Björnstad H, Svendsen TL, Devereux RB: Gender differences in systolic left ventricular function in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE Study). Am J Cardiol 2001; 87: 980-983. (Pubitemid 32299983)
24. Thrainsdottir IS, Hardarson T, Thorgeirsson G, Sigvaldason H, Sigfusson N: Survival and trends of occurrence of left ventricular hypertrophy, gender differences, 1967-92: the Reykjavik Study. J Intern Med 2003; 253: 418-424.
25. Yildiz A, Memisoglu E, Oflaz H, Yazici H, Pusuroglu H, Akkaya V, Erzengin F, Tepe S: Atherosclerosis and vascular calcification are independent predictors of left ventricular hypertrophy in chronic haemodialysis patients. Nephrol Dial Transplant 2005; 20: 760-767. (Pubitemid 40520654)
26. Drighil A, Madias JE, Benjelloun M, Kamoum H, Bennis A, Azzouzi L, Yazidi A, Bamdani B: Changes in the QT intervals, QT dispersion, and amplitude of T waves after hemodialysis. Ann Noninvasive Electrocardiol 2007; 12: 137-144. (Pubitemid 46889920)
27. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM: Arterial calcifications, arterial stiffness, and cardiovascular risk in endstage renal disease. Hypertension 2001; 38: 938-942. (Pubitemid 34258697)